The Curious Case of the Barbed Hairs

An itsy bitsy problem that could not be washed out.

Read Article
  • AMD in 2017

    A Review of Treatment Guidelines and the Role of Early Appropriate Therapy

    Read Article
  • Diabetes Awareness Month
  • OCT-A Disease Education Resource Center
  • AMD Awareness Month
  • DME Disease Education Resource Center
  • Uveitis Resource Center
  • ZEISS OCT Angiography eNewsletter Series
  • AMD Disease Education Resource Center
  • Articles From This Issue


    The Curious Case of the Barbed Hairs

    Cover Focus: Mystery Cases

    A 19-year-old woman had experienced recurrent episodes of episcleritis in the left eye for more than 3 months despite a variety of treatment regimens, including topical an…

    Elementary, My Dear Fellow

    Editors’ Message

    Retina doctors spend their careers reading the works of successful ophthalmologists who publish in trade publications and peer reviewed journals; rarely do they spend t…


    Supplements and Inserts

    High-Speed Cutting: Implications for Tractional Forces

    One of the key components of successful and safe retina surgery is the ability to engage target tissue while causing minimal or no disruption of adjacent tissue. Whether dissecting hyaloid near the retina, peeling a membrane, or performing core vitrectomy, the surgeon must be ever mindful of tractional forces and how much stress the intraocular maneuvers are placing on the retina-vitreous interface.

    A Review of DME Treatment Guidelines and the Role of Early Appropriate Therapy

    The prevalence of diabetes is growing globally; as such the number of people affected by vision-threatening diabetic retinopathy (DR) is likewise expected to continue to increase. Prevent Blindness America has estimated more than 7.6 million people in the United States have DR as a result of their systemic disorder.1

    Retina Surgery Without Compromise

    The majority of my cases are operated using 23-gauge instrumentation using valved cannulas whenever possible. While I do use some 25-gauge, I prefer to use the technology with which I am most comfortable. I am not necessarily resistant to change; however, I have been getting very good results with my particular setup for over a decade, and so it is difficult for me to justify modifying my approach.



    ThromboGenics Announces Publication in Experimental Eye Research of Preclinical Data Supporting Therapeutic Potential of THR-317 in DR

    ThromboGenics NV announced that preclinical data on its THR-317 have been published in Experimental Eye Research. ThromboGenics’ preclinical studies are designed to investigate inhibition of pla…

    PanOptica Secures Funding to Advance Clinical Development of PAN-9080 Topical Anti-VEGF Eye Drop

    PanOptica announced that it has secured $11 million in a Series B financing to enable clinical advancement of PAN-90806, a small molecule anti-vascular endothelial growth factor (anti-VEGF) eye drop f…

    Contact Info

    Bryn Mawr Communications LLC
    1008 Upper Gulph Road, Suite 200
    Wayne, PA 19087

    Phone: 484-581-1800
    Fax: 484-581-1818

    Michael Jones
    Senior Editor

    Janet Burk

    About New Retina MD

    New Retina MD delivers cutting-edge content to retina specialists in their first 15 years of practice. Each issue provides fresh insight from younger physicians plus established mentors on clinical and nonclinical issues affecting ophthalmologists in the earlier stages of their careers. NRMD features surgical pearls, clinical research endeavors, practice management, medical reimbursement and policy, continuing educational requirements, financial planning, innovations, and more.